SI-BONE Future Growth
Future criteria checks 1/6
SI-BONE is forecast to grow earnings and revenue by 21.5% and 16.6% per annum respectively. EPS is expected to grow by 22.4% per annum. Return on equity is forecast to be -14.7% in 3 years.
Key information
21.5%
Earnings growth rate
22.4%
EPS growth rate
| Medical Equipment earnings growth | 14.2% |
| Revenue growth rate | 16.6% |
| Future return on equity | -14.7% |
| Analyst coverage | Good |
| Last updated | 20 Nov 2024 |
Recent future growth updates
Recent updates
Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 12/31/2026 | 227 | -23 | N/A | N/A | 8 |
| 12/31/2025 | 194 | -25 | N/A | N/A | 9 |
| 12/31/2024 | 165 | -32 | N/A | N/A | 9 |
| 9/30/2024 | 157 | -37 | -25 | -16 | N/A |
| 6/30/2024 | 151 | -41 | -26 | -18 | N/A |
| 3/31/2024 | 144 | -43 | -23 | -16 | N/A |
| 12/31/2023 | 139 | -43 | -27 | -19 | N/A |
| 9/30/2023 | 132 | -44 | -32 | -23 | N/A |
| 6/30/2023 | 124 | -48 | -38 | -28 | N/A |
| 3/31/2023 | 117 | -55 | -49 | -39 | N/A |
| 12/31/2022 | 106 | -61 | -51 | -42 | N/A |
| 9/30/2022 | 100 | -65 | -57 | -48 | N/A |
| 6/30/2022 | 96 | -66 | -57 | -50 | N/A |
| 3/31/2022 | 92 | -62 | -50 | -44 | N/A |
| 12/31/2021 | 90 | -57 | -46 | -40 | N/A |
| 9/30/2021 | 87 | -51 | -40 | -35 | N/A |
| 6/30/2021 | 85 | -45 | -36 | -31 | N/A |
| 3/31/2021 | 77 | -43 | -34 | -31 | N/A |
| 12/31/2020 | 73 | -44 | -33 | -31 | N/A |
| 9/30/2020 | 71 | -44 | -34 | -32 | N/A |
| 6/30/2020 | 67 | -46 | -36 | -33 | N/A |
| 3/31/2020 | 69 | -42 | -37 | -34 | N/A |
| 12/31/2019 | 67 | -38 | -34 | -32 | N/A |
| 9/30/2019 | 63 | -35 | -31 | -29 | N/A |
| 6/30/2019 | 60 | -28 | -25 | -24 | N/A |
| 3/31/2019 | 58 | -23 | -18 | -17 | N/A |
| 12/31/2018 | 55 | -17 | -15 | -15 | N/A |
| 9/30/2018 | 54 | -17 | -13 | -12 | N/A |
| 6/30/2018 | 52 | -18 | N/A | -14 | N/A |
| 3/31/2018 | 49 | -21 | N/A | -17 | N/A |
| 12/31/2017 | 48 | -23 | N/A | -18 | N/A |
| 3/31/2017 | 44 | -21 | N/A | -16 | N/A |
| 12/31/2016 | 42 | -21 | N/A | -17 | N/A |
| 3/31/2016 | 40 | -27 | N/A | -25 | N/A |
| 12/31/2015 | 41 | -28 | N/A | -27 | N/A |
| 9/30/2015 | 42 | -32 | N/A | -27 | N/A |
| 3/31/2015 | 40 | -32 | N/A | -29 | N/A |
| 12/31/2014 | 40 | -28 | N/A | -26 | N/A |
| 12/31/2013 | 49 | -6 | N/A | -1 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: 2K3 is forecast to remain unprofitable over the next 3 years.
Earnings vs Market: 2K3 is forecast to remain unprofitable over the next 3 years.
High Growth Earnings: 2K3 is forecast to remain unprofitable over the next 3 years.
Revenue vs Market: 2K3's revenue (16.6% per year) is forecast to grow faster than the German market (5.6% per year).
High Growth Revenue: 2K3's revenue (16.6% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: 2K3 is forecast to be unprofitable in 3 years.